当前位置：首页 > 文献互助 > 互助详情

Fine-Tuning the Active-Site Microenvironment of β-Galactosidase to Enhance the Synthesis Ability of Galactooligosaccharides while Minimizing the Impairment to Transglycosylation Activity复制

鱼鱼呀 1小时前 9 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-03-06 16:29:48 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1021/acs.jafc.5c00679复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.jafc.5c00679复制

其他信息:

上一篇：Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia

下一篇：Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia

互助时间线

2026-02-27 16:33:22 [完结求助]

楼主确认了期刊小观察应助的文件是正确的, 求助状态变成 已完结

2026-02-27 16:29:48 [上传文件]

期刊小观察上传了文件(pdf 12.69 MB), 求助状态变成 待确认

2026-02-27 16:29:10 [发起求助]

最新发布的求助

Design, synthesis and anti-breast cancer activity evaluation of 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine-based PARP1/ATR dual inhibitors 26分钟前
Synthesis of Unsymmetrical Ketones Using Chelation-Controlled Sequential Substitution of N-Triazinylamide/Weinreb Amide by Organometallic Reagents 1小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 1小时前
Fine-Tuning the Active-Site Microenvironment of β-Galactosidase to Enhance the Synthesis Ability of Galactooligosaccharides while Minimizing the Impairment to Transglycosylation Activity 1小时前
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia 1小时前
† Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production 1小时前
Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation 1小时前
Emerging Medical Therapies for Primary Aldosteronism 1小时前
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer 2小时前
Biomarkers for Cardiovascular Drug Development 2小时前
Heart Failure Prevention 2小时前
Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com